Novel [(3-indolylmethylene)hydrazono]indolin-2-ones as apoptotic anti-proliferative agents: design, synthesis and in vitro biological evaluation. 2018

Wagdy M Eldehna, and Mahmoud F Abo-Ashour, and Hany S Ibrahim, and Ghada H Al-Ansary, and Hazem A Ghabbour, and Mahmoud M Elaasser, and Hanaa Y A Ahmed, and Nesreen A Safwat
a Department of Pharmaceutical Chemistry, Faculty of Pharmacy , Kafrelsheikh University , Kafrelsheikh , Egypt.

On account of their significance as apoptosis inducing agents, merging indole and 3-hydrazinoindolin-2-one scaffolds is a logic tactic for designing pro-apoptotic agents. Consequently, 27 hybrids (6a-r, 9a-f and 11a-c) were synthesised and evaluated for their cytotoxicity against MCF-7, HepG-2 and HCT-116 cancer cell lines. SAR studies unravelled that N-propylindole derivatives were the most active compounds such as 6n (MCF-7; IC50=1.04 µM), which displayed a significant decrease of cell population in the G2/M phase and significant increase in the early and late apoptosis by 19-folds in Annexin-V-FTIC assay. Also, 6n increased the expression of caspase-3, caspase-9, cytochrome C and Bax and decreased the expression of Bcl-2. Moreover, compounds 6i, 6j, 6n and 6q generated ROS by significant increase in the level of SOD and depletion of the levels of CAT and GSH-Px in MCF-7.

UI MeSH Term Description Entries
D007211 Indoles Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006835 Hydrazones Compounds of the general formula R:N.NR2, as resulting from the action of hydrazines with aldehydes or ketones. (Grant & Hackh's Chemical Dictionary, 5th ed) Hydrazone
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis

Related Publications

Wagdy M Eldehna, and Mahmoud F Abo-Ashour, and Hany S Ibrahim, and Ghada H Al-Ansary, and Hazem A Ghabbour, and Mahmoud M Elaasser, and Hanaa Y A Ahmed, and Nesreen A Safwat
May 2014, European journal of medicinal chemistry,
Wagdy M Eldehna, and Mahmoud F Abo-Ashour, and Hany S Ibrahim, and Ghada H Al-Ansary, and Hazem A Ghabbour, and Mahmoud M Elaasser, and Hanaa Y A Ahmed, and Nesreen A Safwat
August 2017, Bioorganic & medicinal chemistry letters,
Wagdy M Eldehna, and Mahmoud F Abo-Ashour, and Hany S Ibrahim, and Ghada H Al-Ansary, and Hazem A Ghabbour, and Mahmoud M Elaasser, and Hanaa Y A Ahmed, and Nesreen A Safwat
January 2023, International journal of molecular sciences,
Wagdy M Eldehna, and Mahmoud F Abo-Ashour, and Hany S Ibrahim, and Ghada H Al-Ansary, and Hazem A Ghabbour, and Mahmoud M Elaasser, and Hanaa Y A Ahmed, and Nesreen A Safwat
January 2023, Future medicinal chemistry,
Wagdy M Eldehna, and Mahmoud F Abo-Ashour, and Hany S Ibrahim, and Ghada H Al-Ansary, and Hazem A Ghabbour, and Mahmoud M Elaasser, and Hanaa Y A Ahmed, and Nesreen A Safwat
December 2018, Journal of enzyme inhibition and medicinal chemistry,
Wagdy M Eldehna, and Mahmoud F Abo-Ashour, and Hany S Ibrahim, and Ghada H Al-Ansary, and Hazem A Ghabbour, and Mahmoud M Elaasser, and Hanaa Y A Ahmed, and Nesreen A Safwat
October 2015, Bioorganic & medicinal chemistry letters,
Wagdy M Eldehna, and Mahmoud F Abo-Ashour, and Hany S Ibrahim, and Ghada H Al-Ansary, and Hazem A Ghabbour, and Mahmoud M Elaasser, and Hanaa Y A Ahmed, and Nesreen A Safwat
May 2009, Bioorganic & medicinal chemistry letters,
Wagdy M Eldehna, and Mahmoud F Abo-Ashour, and Hany S Ibrahim, and Ghada H Al-Ansary, and Hazem A Ghabbour, and Mahmoud M Elaasser, and Hanaa Y A Ahmed, and Nesreen A Safwat
November 2008, European journal of medicinal chemistry,
Wagdy M Eldehna, and Mahmoud F Abo-Ashour, and Hany S Ibrahim, and Ghada H Al-Ansary, and Hazem A Ghabbour, and Mahmoud M Elaasser, and Hanaa Y A Ahmed, and Nesreen A Safwat
July 2023, RSC advances,
Wagdy M Eldehna, and Mahmoud F Abo-Ashour, and Hany S Ibrahim, and Ghada H Al-Ansary, and Hazem A Ghabbour, and Mahmoud M Elaasser, and Hanaa Y A Ahmed, and Nesreen A Safwat
February 2015, Marine drugs,
Copied contents to your clipboard!